Zebra Capital Management LLC Travere Therapeutics, Inc. Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $136,874 - $263,941
-10,545 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$14.11 - $26.4 $16,071 - $30,069
-1,139 Reduced 9.75%
10,545 $154,000
Q1 2021

May 17, 2021
SELL
$23.37 - $31.77 $755,505 - $1.03 Million
-32,328 Reduced 73.45%
11,684 $292,000
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $843,710 - $1.23 Million
44,012 New
44,012 $1.2 Million

Others Institutions Holding TVTX

# of Institutions
184
Shares Held
89.5M
Call Options Held
137K
Put Options Held
181K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.14B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email